Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1626 to 1650 of 2529

TitleReference numberPublishedLast updated
Woundchek Protease Status for assessing elevated protease status in chronic woundsMIB83
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusionTA409
Talimogene laherparepvec for treating unresectable metastatic melanomaTA410
Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancerTA411
Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastasesTA412
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA406
Pegaspargase for treating acute lymphoblastic leukaemiaTA408
Secukinumab for treating active ankylosing spondylitisTA407
Miniature lens system implantation for advanced age-related macular degenerationHTG418
Multimorbidity: clinical assessment and managementNG56
Intravenous fluid therapy in children and young people in hospitalQS131
Social care for older people with multiple long-term conditionsQS132
Harmful sexual behaviour among children and young peopleNG55
QuikRead go for C-reactive protein testing in primary careMIB78
FLEXISEQ for osteoarthritisMIB80
Alere Afinion CRP for C-reactive protein testing in primary careMIB81
Mental health problems in people with learning disabilities: prevention, assessment and managementNG54
ContraceptionQS129
Transition between inpatient mental health settings and community or care home settingsNG53
Stable angina: managementCG126
Acute upper gastrointestinal bleeding in over 16s: managementCG141
Axxent electronic brachytherapy system for early stage breast cancerMIB76
OSNA for colon cancer stagingMIB77
Bosutinib for previously treated chronic myeloid leukaemiaTA401
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatinTA402

Results per page

  1. 10
  2. 25
  3. 50
  4. All